Selective inhibition by kanamycin of focus formation by Rous and Moloney sarcoma viruses.
D000818:Animals; D000998:Antiviral Agents; D001358:Avian Sarcoma Viruses / Q000187:drug effects* / Q000201:enzymology; D002478:Cells, Cultured; D002645:Chickens; D003588:Cytopathogenic Effect, Viral; D007612:Kanamycin / Q000494:pharmacology*; D008979:Moloney murine leukemia virus / Q000187:drug effects*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism; D001357:Sarcoma, Avian / Q000209:etiology; D012513:Sarcoma, Experimental / Q000209:etiology; D014776:Virus Cultivation; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D007612:Kanamycin; D012194:RNA-Directed DNA Polymerase